Pharmacokinetics of Peramivir in an Adolescent Patient Receiving Continuous Venovenous Hemodiafiltration

Critically ill patients requiring renal replacement therapy commonly experience pharmacokinetic alterations. This case report describes the pharmacokinetics of peramivir (Rapivab, BioCryst Pharmaceuticals, Inc, Durham, NC), the first US Food and Drug Administration–approved intravenous neuraminidase...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Pediatr Pharmacol Ther
Hlavní autoři: Dillon, Ryan C., Witcher, Robert, Cies, Jeffrey J., Moore, Wayne S., Chopra, Arun
Médium: Artigo
Jazyk:Inglês
Vydáno: Pediatric Pharmacy Advocacy Group 2017
Témata:
Case Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5341533/
https://ncbi.nlm.nih.gov/pubmed/28337082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-22.1.60
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky